Breathe BioMedical announces new Executive Director
by CM Staff
BBM is focused on developing an accessible, noninvasive breath test to detect breast cancer in women, specifically women with dense breast tissue.
MONCTON — Breathe BioMedical (BBM) announces the appointment of Dr. Rachel Brem to the company’s Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.
Dr. Brem is the Director of the Breast Imaging and Interventional Center at the George Washington University. She is a cutting-edge clinician, researcher with peer-reviewed publications, author of a recently published book, No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care that’s Right for You (Simon and Schuster, 2023), advocate, and a breast cancer survivor.
Throughout her career, Dr. Brem has been involved in developing, implementing technologies to improve the diagnosis and outcomes of breast cancer including artificial intelligence, molecular breast imaging and ultrasound tomography.
BBM is focused on developing an accessible, noninvasive breath test to detect breast cancer in women, specifically women with dense breast tissue. Dr. Brem’s leadership in breast cancer and her leadership in the critically important area of dense breast tissue makes her an optimal addition to their team.
Dr. Brem is the Chief Medical Officer of the Brem Foundation. The Brem Foundation focuses on education, health equity and advocacy on the local and national level and is instrumental in passage of breast cancer legislation. Their mission to maximize women’s chances of finding early, curable breast cancer through education, access, and advocacy is well aligned with BBM’s mission.
“Dr. Brem is a renowned radiologist and researcher in the breast cancer field. Her story is incredibly inspiring and her passion and drive to find early, accessible methods for breast cancer detection is directly aligned with our work and mission at BBM,” said BBM CEO, Bill Dawes. “We are excited to have Dr. Brem’s leadership at the Executive Director level to lead our Clinical and Regulatory strategy as our Chief Medical Officer.”
“The team at BBM is developing technology that will address the challenges of early breast cancer detection to further decrease breast cancer mortality. I look forward to joining BBM to support their development in the breast cancer field,” said Dr. Brem of her new role at BBM.
Dr. Brem received her medical degree from Colombia University, completing an internship in internal medicine at Sinai Hospital and her residency in radiology at John Hopkins Hospital.
